deaths (OS)

glioblastoma (GB) glioblastoma (GB)

metastatic glioblastoma (mGB) - 1st line (L1) metastatic glioblastoma (mGB) - 1st line (L1)

versus bevacizumab
nivolumab alone vs. bevacizumab 1 certainty unassessable+4%